Thomas Martin (pathologist)

Professor Emeritus
Thomas John Martin
Born
Thomas John "Jack" Martin

(1937-01-24) January 24, 1937 (age 87)
EducationUniversity of Melbourne[1][3]
Degrees:
  • Bachelor of Medicine (MB) (1960)[1]
  • Bachelor of Surgery (BS) (1960)[1]
  • Doctor of Medicine (MD) (1969)[1]
  • Doctor of Science (DSc) (1979)[1]
Alma materUniversity of Melbourne
Known forDiscovery of parathyroid hormone-related protein (PTHrP)
Scientific career
Fields
Institutions

Thomas John "Jack" Martin FRACP[2] FRCPA[2] is an Australian pathologist, emeritus professor of medicine, physician and academic at University of Melbourne,[1][3] and researcher who, in 1987, by leading a former team of researchers at the same university, discovered a proteinaceous hormone called parathyroid hormone-related protein (PTHrP).[4][5] In September 2005, further research was conducted by the team of Dengshun Miao[6] and David Goltzman at the Calcium Research Laboratory and Department of Medicine, Royal Victoria Hospital of the McGill University Health Centre, and others.[6]

Martin is a member of Natalie A. Sims' laboratory[7] at Saint Vincent's Institute of Medical Research.[8] He works in the institute's Division of Medicine, Dentistry and Health Sciences, and his primary interest is cell biology of bones.[9]

  1. ^ a b c d e f g h i j k l m Centre for Transformative Innovation, Swinburne University of Technology. "Martin, Thomas John (Jack)". Encyclopedia of Australian Science and Innovation. Archived from the original on January 1, 2023. Retrieved October 30, 2022.
  2. ^ a b c d e f g h i "Prof T.J. (Jack) Martin". Saint Vincent's Institute. Archived from the original on October 30, 2022. Retrieved October 30, 2022.
  3. ^ a b Fioritti, Nathan (November 22, 2016). "Professor Emeritus Thomas John Martin AO". Faculty of Medicine, Dentistry and Health Sciences. Archived from the original on October 29, 2022. Retrieved October 30, 2022.
  4. ^ Martin TJ, Moseley JM, Gillespie MT (1991). "Parathyroid hormone-related protein: biochemistry and molecular biology". Critical Reviews in Biochemistry and Molecular Biology. 26 (3–4): 377–395. doi:10.3109/10409239109114073. PMID 1935171. Archived from the original on October 17, 2022. Retrieved October 29, 2022.
  5. ^ US patent 5460978A, Martin TJ, Moseley JM, Kemp BE, Wettenhall RE, "Protein active in humoral hypercalcemia of malignancy-PthrP", issued October 24, 1995, assigned to University of Melbourne 
  6. ^ a b Miao, D.; He, B.; Jiang, Y.; Kobayashi, T.; Sorocéanu, M. A.; Zhao, J.; et al. (September 2005). "Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34". The Journal of Clinical Investigation. 115 (9): 2402–2411. doi:10.1172/JCI24918. PMC 1193882. PMID 16138191.
  7. ^ Sims, Natalie A. "Natalie A Sims's Lab". ResearchGate.
  8. ^ Martin, Thomas J. "Thomas Martin - Saint Vincent's Institute". ResearchGate. Archived from the original on August 11, 2022. Retrieved October 29, 2022.
  9. ^ "Prof Thomas Martin". Find an Expert - University of Melbourne. Archived from the original on November 4, 2022. Retrieved October 29, 2022.